Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
- 5 December 2002
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 249 (1-2), 127-138
- https://doi.org/10.1016/s0378-5173(02)00483-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulationInternational Journal of Pharmaceutics, 2001
- Effect of the molecular weight of poly(ɛ-caprolactone-co-?lactide) on toremifene citrate release from copolymer/silica xerogel compositesInternational Journal of Pharmaceutics, 2001
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- A Novel Route To Poly(ε-caprolactone)-Based Copolymers via Anionic DerivatizationBiomacromolecules, 2000
- Enzymatic degradation of poly(ε-caprolactone)/poly(dl-lactide) blends in phosphate buffer solutionPolymer, 1999
- A novel laser light-scattering study of enzymatic biodegradation of poly(ε-caprolactone) nanoparticlesPolymer, 1999
- Designer EstrogensScientific American, 1998
- Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicityInternational Journal of Pharmaceutics, 1997
- Fighting Cancer by Attacking its Blood SupplyScientific American, 1996
- Barriers to Drug Delivery in Solid TumorsScientific American, 1994